Associated Papers
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation.
Gaebler C et al.
Nature, 2026
Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study.
Henrich TJ et al.
Open Forum Infectious Diseases, 2014
Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia.
Zapata W et al.
Aids Research and Human Retroviruses, 2013
Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians.
Malhotra R et al.
Retrovirology, 2011
Haplotype structure and linkage disequilibrium in chemokine and chemokine receptor genes.
Clark VJ et al.
Human Genomics, 2004
CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy.
Tang J et al.
Aids Research and Human Retroviruses, 2002
Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.
Tang J et al.
Journal of Virology, 2002
C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection.
Dorak MT et al.
Immunologic Research, 2002
Statistical estimation and pedigree analysis of CCR2-CCR5 haplotypes.
Clark VJ et al.
Human Genetics, 2001
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.
Gonzalez E et al.
Proceedings of the National Academy of Sciences of the United States of America, 1999
Select a paper to view details